Dr. Hamid on Patient Selection for Immunotherapy Regimens in Melanoma

Omid A. Hamid, MD
Published: Friday, Dec 30, 2016



Omid A. Hamid, MD, chief, Translational Research and Immunotherapy, director, Melanoma Therapeutics, The Angeles Clinic and Research Institute, discusses how to accurately select patients who are likely to have durable and long responses with single-agent immunotherapy versus combination treatment.

Specifically, Hamid explains, the question should be, "Who will respond best to single-agent immunotherapy or to one of the many combinations, whether they be in clinical trials or are approved by the FDA?" Steps to evaluate this will be with newer assays beyond PD-L1 staining, mutational load status, CD8-positive T-cells in the tumor biopsy specimen, and exhausted T-cell phenotypes.

These are all approaches that have been explored and presented, and will be reviewed in the near future.  


Omid A. Hamid, MD, chief, Translational Research and Immunotherapy, director, Melanoma Therapeutics, The Angeles Clinic and Research Institute, discusses how to accurately select patients who are likely to have durable and long responses with single-agent immunotherapy versus combination treatment.

Specifically, Hamid explains, the question should be, "Who will respond best to single-agent immunotherapy or to one of the many combinations, whether they be in clinical trials or are approved by the FDA?" Steps to evaluate this will be with newer assays beyond PD-L1 staining, mutational load status, CD8-positive T-cells in the tumor biopsy specimen, and exhausted T-cell phenotypes.

These are all approaches that have been explored and presented, and will be reviewed in the near future.  



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x